Skip to main content
. 2019 Feb 18;2019:6704031. doi: 10.1155/2019/6704031

Table 2.

Antithrombotic therapy before and after left atrial appendage closure.

Pretreatment Posttreatment, discharge Posttreatment, 3 months Posttreatment, 6/12 months
n 68 68 68 62
No antithrombotic therapy 16 (23.5%) 5 (7.3%) 10 (14.7%) 20 (32.3%)
Single anti-platelet therapy 12 (17.7%) 29 (42.7%) 40 (58.9%) 34 (54.8%)
Dual anti-platelet therapy 23 (33.8%) 32 (47.1%) 16 (23.5%) 8 (12.9%)
Anticoagulant therapy 17 (25.0%) 2 (2.9%) 2 (2.9%) 0 (0.0%)